Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
18.38
+0.52 (2.91%)
At close: Aug 14, 2026, 4:00 PM EDT
18.26
-0.12 (-0.65%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Erasca Employees
Erasca had 103 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
103
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,788,573
Market Cap
6.43B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 0 | - |
| Dec 31, 2024 | 103 | -23 | -18.25% |
| Dec 31, 2023 | 126 | -3 | -2.33% |
| Dec 31, 2022 | 129 | 6 | 4.88% |
| Dec 31, 2021 | 123 | 21 | 20.59% |
| Jun 30, 2021 | 102 | - | - |
| Mar 31, 2021 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
ERAS News
- 4 hours ago - Erasca price target raised to $20 from $18 at BofA - TheFly
- 4 days ago - Erasca reports Q2 EPS (14c), consensus (11c) - TheFly
- 4 days ago - Erasca Reports Second Quarter 2026 Business Updates and Financial Results - GlobeNewsWire
- 4 days ago - Erasca Earnings release: Q2 2026 - Filings
- 4 days ago - Erasca Quarterly report: Q2 2026 - Filings
- 5 days ago - Erasca Slides: Corporate presentation - Filings
- 13 days ago - Kaplan Fox Notifies Erasca, Inc. (ERAS) Investors of an Upcoming Lead Plaintiff Deadline on August 10, 2026 - Newsfile Corp
- 17 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 10, 2026 in Erasca, Inc. Lawsuit - ERAS - PRNewsWire